MTAP and glioblastoma: In the pediatric context, 40 pediatric glioblastoma patients included in the analysis—86.3% (n = 19) in the MTAP-negative group and 77.7% (n = 14) in the MTAP-positive group—died during the total observational time (Figure 4B).